首页> 外文期刊>Cancer letters >Sorting nexin 10 acts as a tumor suppressor in tumorigenesis and progression of colorectal cancer through regulating chaperone mediated autophagy degradation of p21(Cip1/WAF1)
【24h】

Sorting nexin 10 acts as a tumor suppressor in tumorigenesis and progression of colorectal cancer through regulating chaperone mediated autophagy degradation of p21(Cip1/WAF1)

机译:通过调节P21的伴侣介导的自噬降(CIP1 / WAF1),将Nexin 10分类为肿瘤抑制和结肠直肠癌进展的肿瘤抑制作用(CIP1 / WAF1)

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Chaperone-mediated autophagy (CMA) characterized by the selective degradation of target proteins has been linked with tumorigenesis in recent years. Here, we explored the function of sorting nexin 10 (SNX10), a protein involved in maintaining endosome/lysosome homeostasis, in mediating CMA activity and its impact on the progression of mouse inflammation-driven colorectal cancer. Our results revealed that SNX10 deficiency increased the activation of CMA by preventing the degradation of lysosomal LAMP-2A. In SNX10 KO cells, we disclosed that p21(Cip1/WAF1). a master effector in various tumor suppressor pathways, is a substrate of CMA, and decrease of p21(Cip1/WAF1) caused by SNX10-mediated CMA activation contributes to HCT116 cell proliferation and survival. Moreover, we found that SNX10 KO promoted tumorigenesis in the mouse colorectum which could be restored by SNX10 over-expression. Furthermore, SNX10 was remarkably down-regulated in. human CRC tissues which showed the increased activity of CMA and decreased expression of p21(Cip1/lWAF1). These findings suggest that SNX10 acts as a tumor suppressor in the mouse colorectum and drives inflammation-associated colorectal cancer by a chaperone-mediated autophagy mechanism. (C) 2018 Elsevier B.V. All rights reserved.
机译:伴随着靶蛋白选择性降解的伴侣介导的自噬(CMA)与近年来的肿瘤引发有关。在这里,我们探讨了在介导CMA活性和对小鼠炎症驱动的结直肠癌进展的介导的CMA活性和影响中,探讨了Nexin 10(SNX10)的功能,该蛋白质,其参与维持内肢/溶酶体稳态病症。我们的研究结果表明,通过防止溶酶体灯-2a的降解,SNX10缺乏增加了CMA的激活。在SNX10 KO细胞中,我们公开了P21(CIP1 / WAF1)。各种肿瘤抑制途径中的母效应器是CMA的基材,并且由SNX10介导的CMA活化引起的P21(CIP1 / WAF1)的降低有助于HCT116细胞增殖和存活。此外,我们发现SNX10 KO在小鼠结肠直肠中促进了肿瘤发生,其可以通过SNX10过表达恢复。此外,SNX10显着下调。人类CRC组织,其显示CMA活性增加并降低P21的表达(CIP1 / LWAF1)。这些发现表明,SNX10作为小鼠结肠抑制的肿瘤抑制剂,通过伴侣介导的自噬机制驱动炎症相关结肠直肠癌。 (c)2018 Elsevier B.v.保留所有权利。

著录项

  • 来源
    《Cancer letters》 |2018年第2018期|共12页
  • 作者单位

    Fudan Univ Sch Pharm Dept Pharmacol 826 Zhangheng Rd Shanghai 201203 Peoples R China;

    Fudan Univ Sch Pharm Dept Pharmacol 826 Zhangheng Rd Shanghai 201203 Peoples R China;

    Fudan Univ Sch Pharm Dept Pharmacol 826 Zhangheng Rd Shanghai 201203 Peoples R China;

    Shanghai Jiao Tong Univ Affiliated Shanghai Peoples Hosp 1 Songjiang Hosp Dept Pharm Shanghai;

    Fudan Univ Sch Pharm Dept Pharmacol 826 Zhangheng Rd Shanghai 201203 Peoples R China;

    Fudan Univ Sch Pharm Dept Pharmacol 826 Zhangheng Rd Shanghai 201203 Peoples R China;

    Fudan Univ Sch Pharm Dept Pharmacol 826 Zhangheng Rd Shanghai 201203 Peoples R China;

    Fudan Univ Sch Pharm Dept Pharmacol 826 Zhangheng Rd Shanghai 201203 Peoples R China;

    Fudan Univ Sch Pharm Dept Pharmacol 826 Zhangheng Rd Shanghai 201203 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    SNX10; Chaperone-mediated autophagy; Colorectal cancer; p21(Cip1/WAF1);

    机译:SNX10;伴侣介导的自噬;结肠直肠癌;P21(CIP1 / WAF1);

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号